Evidence map›Paper›PMID 38499391›Full record

ArticleAging2024

Correlation between S100A7 and immune characteristics, methylation, tumor stemness and tumor heterogeneity in pan-cancer and its role in chemotherapy resistance in breast cancer.

Yilun Li, Xiaolu Yang, Tingting Jin, Qiuli Li, Xiaolong Li, Li Ma

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yilun LiDepartment of Breast Disease Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Xiaolu YangDepartment of Breast Disease Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Tingting JinDepartment of Pathology, Hebei Medical University, Shijiazhuang, China.
Qiuli LiDepartment of Pathology, Hebei Medical University, Shijiazhuang, China.
Xiaolong LiDepartment of Breast Disease Center, The Fourth Hospital of Shijiazhuang, Shijiazhuang, China.
Li MaDepartment of Breast Disease Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Medical University · CNFourth Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the relationships between

methodsTCGA-BRCA and TCGA-PANCANCER RNA-seq data and clinical follow-up survival data were collected from the University of California Santa Cruz database. Survival analyses were performed to explore the relationship between

results

conclusionHigh

Indexed as

Mammary Neoplasms, AnimalAdjuvants, ImmunologicAnimalsBiological AssayHumansMethylationProtein Processing, Post-TranslationalS100 Calcium Binding Protein A7Adjuvants, ImmunologicS100A7 protein, humanS100 Calcium Binding Protein A7chemotherapy resistanceheterogeneitymethylationS100A7tumor stemness

Identifiers

PMID38499391
PMCPMC11006463
OpenAlexW4392912475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.